Steven Klein, MD
Maternal & Fetal Medicine · Mineola, NYNPI 1013137017
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,395 of the $1,734 with a category attached, or 80.4%. 16 manufacturers reported payments, led by Astellas Pharma US Inc at 31.6% of the total. Among maternal & fetal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$548
- Amgen$235
- AbbVie$175
- Pfizer$125
- Millicent US Inc$115
- Mayne Pharma Commercial LLC$104
- plus $432 from 10 others
What the payments were for
- Food & beverage$1,39580%
- Education$33920%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 15 | $548 |
| Amgen | 14 | $235 |
| AbbVie | 10 | $175 |
| Pfizer | 7 | $125 |
| Millicent US Inc | 7 | $115 |
| Mayne Pharma Commercial LLC | 6 | $104 |
| Merck | 5 | $95 |
| Therapeuticsmd, Inc. | 4 | $59 |
| Osmotica Pharmaceutical Corp. | 1 | $54 |
| Exeltis, USA Inc. | 3 | $50 |
| Scynexis, Inc. | 3 | $49 |
| Myovant Sciences Inc. | 2 | $33 |
| Evofem Biosciences, Inc. | 2 | $33 |
| Lupin Inc. | 2 | $27 |
| Duchesnay USA Incorporated | 1 | $18 |
| Coopersurgical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$125
How this compares
$1,734 in reported general payments places this provider in the 90th percentile of 185 maternal & fetal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 50 | $3,893 |
| Estradiol (Once Weekly)Estradiol | 31 | $2,485 |
| YuvafemEstradiol | 18 | $2,128 |
| Estradiol (Twice Weekly)Estradiol | 13 | $1,386 |
| Clobetasol Propionate | 23 | $1,181 |
| ValacyclovirValacyclovir Hcl | 17 | $808 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $224 |
| Fluconazole | 22 | $151 |
Paid to pharmacies, not to this prescriber.
Other maternal & fetal medicine in Mineola
- Martin ChavezMineola$310K
- Wendy KinzlerMineola$430
- Heather LipkindNew York$60K
- Mary DaltonNew York$58K
- Eran BornsteinNew York$56K
- Ilan TimorNew York$36K
- Lisa NathanNew York$32K
- Daniel SkupskiFlushing$17K
- Ellen LandsbergerLarchmont$12K
- Kevin JovanovicNew York$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.